Friedenthal Financial’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-21,574
Closed -$1.1M 289
2026
Q1
$1.1M Buy
+21,574
New +$1.01M 0.55% 33
2024
Q3
Sell
-5,430
Closed -$645K 282
2024
Q2
$645K Buy
+5,430
New +$687K 0.4% 81

Other funds holding MRNA

Friedenthal Financial's MRNA Position: Q2 2026 in Review

Friedenthal Financial sold out of Moderna (MRNA) in Q2 2026, closing a stake of 21,574 shares — an estimated $1.1M sold.

Friedenthal Financial first reported a position in MRNA in Q2 2024 and held it in 2 quarters. The position peaked at $1.1M in Q1 2026. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Friedenthal Financial reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • Friedenthal Financial sold 21,574 Moderna shares in Q2 2026, an estimated $1.1M.
  • Friedenthal Financial first reported a position in Moderna in Q2 2024 and held it in 2 quarters.
  • Friedenthal Financial's Moderna position peaked at $1.1M in Q1 2026.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Friedenthal Financial's 13F filing for Q2 2026, filed 13 Jul 2026.